This inventor holds 1 USPTO granted patent. Top assignee: Kitasato Daiichi Sankyo Vaccine Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Eiji Komatsu - Innovator in Vaccine Development
Eiji Komatsu is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of vaccine development, particularly in the area of whooping cough prevention. His work is characterized by a commitment to advancing public health through innovative solutions.
Latest Patents
Eiji Komatsu holds a patent for a whole-cell bacterial vaccine composition aimed at preventing whooping cough. The objective of this invention is to provide a vaccine that comprises whole cells, whole-cell homogenate, or cell lysate as an immunogen. This innovative approach is crucial for enhancing the effectiveness of vaccines against this respiratory disease.
Career Highlights
Eiji Komatsu is associated with Kitasato Daiichi Sankyo Vaccine Co., Ltd., where he applies his expertise in vaccine research and development. His role at the company allows him to contribute to the advancement of immunization strategies that can save lives and improve health outcomes.
Collaborations
Eiji Komatsu collaborates with Mineo Watanabe, another professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in vaccine technology.
Conclusion
Eiji Komatsu's work in vaccine development highlights his dedication to improving public health through innovative solutions. His contributions, particularly in the area of whooping cough prevention, are vital for advancing medical science and protecting communities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile